These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36919875)

  • 1. Eve's and Adam's rib for prostate cancer screening.
    Lazzeri M; Fasulo V; Tinterri C
    BJU Int; 2023 Jun; 131(6):637-638. PubMed ID: 36919875
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative excess mortality risk after kidney transplantation: Eve's loss or Adam's win?
    von Samson-Himmelstjerna FA; Kolbrink B; Schulte K
    Kidney Int; 2023 Sep; 104(3):619-620. PubMed ID: 37599023
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Prostate-specific antigen-based prostate cancer screening: Past and future.
    Birkeland S
    Int J Urol; 2016 Apr; 23(4):348. PubMed ID: 26839978
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial Comment to Prostate-specific antigen-based prostate cancer screening: Past and future.
    Sakamoto S
    Int J Urol; 2015 Jun; 22(6):532-3. PubMed ID: 25854711
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostate-specific antigen, prostate cancer screening, and the pathologist: what should be our role?
    Jackson BR
    Arch Pathol Lab Med; 2013 Mar; 137(3):308-9. PubMed ID: 22799565
    [No Abstract]   [Full Text] [Related]  

  • 6. Recommendations on screening for prostate cancer with the prostate-specific antigen test.
    Bell N; Connor Gorber S; Shane A; Joffres M; Singh H; Dickinson J; Shaw E; Dunfield L; Tonelli M;
    CMAJ; 2014 Nov; 186(16):1225-34. PubMed ID: 25349003
    [No Abstract]   [Full Text] [Related]  

  • 7. Doing it right: how, not whether, to perform prostate-specific antigen screening.
    Martin NE
    Eur Urol; 2015 Sep; 68(3):361-2. PubMed ID: 25794459
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation : analysis of trends over time.
    Haines IE
    Cancer; 2013 Mar; 119(5):1113. PubMed ID: 23097055
    [No Abstract]   [Full Text] [Related]  

  • 9. [Screening for prostate cancer using prostate-specific antigen (PSA) : A commentary on a systematic review and meta-analysis].
    Borkowetz A
    Urologe A; 2019 Aug; 58(8):925-928. PubMed ID: 31240375
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostate-specific antigen screening for prostate cancer in males older than 75 years.
    Luján M; Páez Á
    Med Clin (Barc); 2019 Mar; 152(6):237-240. PubMed ID: 30220470
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation : analysis of trends over time.
    Scosyrev E; Messing EM
    Cancer; 2013 Mar; 119(5):1113-4. PubMed ID: 23097014
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of recommendations against prostate cancer screening with prostate specific antigen].
    Abascal Junquera JM; Fumadó Ciutat L; Francés Comalat A; Cecchini Rosell L
    Med Clin (Barc); 2016 Oct; 147(8):361-365. PubMed ID: 27085747
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: National Prostate Cancer Screening Rates after the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.
    Taneja SS
    J Urol; 2016 Feb; 195(2):350-1. PubMed ID: 26852972
    [No Abstract]   [Full Text] [Related]  

  • 14. Prostate specific antigen for detecting early prostate cancer.
    Ilic D; Green S
    BMJ; 2009 Sep; 339():b3572. PubMed ID: 19778970
    [No Abstract]   [Full Text] [Related]  

  • 15. PSA screening for prostate cancer.
    Wilt TJ; Dahm P
    BMJ; 2014 Apr; 348():g2559. PubMed ID: 24736396
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostate Cancer Screening.
    Walsh PC
    N Engl J Med; 2017 Jun; 376(24):2401-2. PubMed ID: 28614679
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostate Cancer Screening.
    Pinsky PF; Prorok PC; Kramer BJ
    N Engl J Med; 2017 Jun; 376(24):2402. PubMed ID: 28614680
    [No Abstract]   [Full Text] [Related]  

  • 18. The dilemmas of prostate cancer screening.
    Haines IE
    Med J Aust; 2013 Nov; 199(9):582-3. PubMed ID: 24182215
    [No Abstract]   [Full Text] [Related]  

  • 19. The dilemmas of prostate cancer screening.
    Del Mar CB
    Med J Aust; 2013 Nov; 199(9):584. PubMed ID: 24182218
    [No Abstract]   [Full Text] [Related]  

  • 20. The dilemmas of prostate cancer screening.
    Hugosson J; Carlsson SV
    Med J Aust; 2013 Nov; 199(9):583-4. PubMed ID: 24182217
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.